Patterns and Risk of Metastatic Infections in Staphylococcus aureus Bacteremia
Overview
In a retrospective cohort of 1725 patients with Staphylococcus aureus bacteremia (SAB), 16.7% developed metastatic infections, predominantly within the first 7 days post-diagnosis. The risk and distribution of metastatic infections varied significantly by the primary infection focus, with endocarditis patients exhibiting the highest incidence at 73.4%.
Background
Staphylococcus aureus bacteremia is a serious infection associated with high morbidity and mortality, often complicated by metastatic infections that worsen outcomes. Early identification and management of these secondary infections are critical, as they require prolonged therapy and intensive monitoring. Prior studies have reported variable metastatic infection rates but lacked detailed analysis of how the primary infection site influences metastatic risk and distribution. This study addresses this gap by evaluating timing, frequency, and anatomical patterns of metastatic infections in a large SAB cohort.
Data Highlights
Parameter
Value
Total patients with SAB
1725
Patients with metastatic infections
289 (16.7%)
Total metastatic infection events
439
Metastatic infections within 7 days
~85%
Incidence of metastatic infection in endocarditis
73.4%
Most frequent metastatic sites
Lung (23.7%), Bones and joints (16.8%), CNS (12.3%)
Key Findings
Metastatic infections occurred in 16.7% of SAB patients within 90 days, with most events (85%) occurring in the first week after diagnosis.
The primary infection focus strongly influenced metastatic risk; endocarditis had the highest metastatic infection rate at 73.4%.
The lung was the most common metastatic site, followed by bones and joints, and the central nervous system.
Distribution of metastatic sites varied significantly depending on the initial infection focus.
Standardized infectious disease consultations and evaluations were integral to identifying metastatic infections early.
Clinical Implications
Clinicians should prioritize early and thorough evaluation for metastatic infections in SAB patients, especially within the first 7 days of diagnosis. Particular vigilance is warranted for patients with endocarditis due to their markedly increased risk. Tailoring diagnostic imaging and monitoring strategies based on the primary infection focus can improve detection and guide timely interventions.
Conclusion
This study highlights the critical importance of the primary infection focus and timing in the risk and anatomical distribution of metastatic infections in SAB. These insights support a more targeted and proactive clinical approach to managing SAB patients to improve outcomes.
References
Patterns and Risk of Metastatic Infections Originating from Primary Sites in Staphylococcus aureus Bacteremia
